Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis

BACKGROUND & AIMS: We created and validated a clinical decision support tool (CDST) to predict outcomes of vedolizumab therapy for ulcerative colitis (UC). METHODS: We performed logistic regression analyses of data from the GEMINI 1 trial, from 620 patients with UC who received vedolizumab induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dulai, Parambir S., Singh, Siddharth, Casteele, Niels Vande, Meserve, Joseph, Winters, Adam, Chablaney, Shreya, Aniwan, Satimai, Shashi, Preeti, Kochhar, Gursimran, Weiss, Aaron, Koliani-Pace, Jenna L., Gao, Youran, Boland, Brigid S., Chang, John T., Faleck, David, Hirten, Robert, Ungaro, Ryan, Lukin, Dana, Sultan, Keith, Hudesman, David, Chang, Shannon, Bohm, Matthew, Varma, Sashidhar, Fischer, Monika, Shmidt, Eugenia, Swaminath, Arun, Gupta, Nitin, Rosario, Maria, Jairath, Vipul, Guizzetti, Leonardo, Feagan, Brian G., Siegel, Corey A., Shen, Bo, Kane, Sunanda, Loftus, Edward V., Sandborn, William J., Sands, Bruce E., Colombel, Jean-Frederic, Lasch, Karen, Cao, Charlie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899124/
https://www.ncbi.nlm.nih.gov/pubmed/32062041
http://dx.doi.org/10.1016/j.cgh.2020.02.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899124/
https://www.ncbi.nlm.nih.gov/pubmed/32062041
http://dx.doi.org/10.1016/j.cgh.2020.02.010

Ejemplares similares